ODI PHARMA AB revenue breakdown overview

ODI PHARMA AB revenue for the last year amounted to 22.40 M SEK, the most of which — 22.29 M SEK — came from its highest performing source at the moment, Pharmaceuticals Cannabis and Cosmetic Products, the year earlier bringing 139.46 k SEK. The greatest contribution to the revenue figure was made by Sweden — last year it brought ODI PHARMA AB 22.29 M SEK, and the year before that — 139.46 k SEK.